Arkolith/Insider Trading/SGP/Form 4/A

Nielsen Kirk G.

DirectorSpyGlass Pharma, Inc. (SGP) · full profile →Form 4/A · filed Feb 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)1.7M——0
Feb 9, 2026Conversion(C)359K——0
Feb 9, 2026Conversion(C)548K——0
Feb 9, 2026Conversion(C)548K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193125-26-046833) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for SpyGlass Pharma, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp